Mineralys Therapeutics (MLYS) Share-based Compensation (2022 - 2026)
Quarterly results put Share-based Compensation at $6.5 million for Q1 2026, up 79.64% from a year ago — trailing twelve months through Mar 2026 was $22.2 million (up 73.78% YoY), and the annual figure for FY2025 was $19.3 million, up 70.47%.
Mineralys Therapeutics has reported Share-based Compensation over the past 5 years, most recently at $6.5 million for Q1 2026.
- Share-based Compensation reached $6.5 million in Q1 2026 per MLYS's latest filing, up from $5.3 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $6.5 million in Q1 2026 and bottomed at $19000.0 in Q1 2022.
- Median Share-based Compensation over the past 5 years was $2.2 million (2024), compared with a mean of $2.5 million.
- The largest annual shift saw Share-based Compensation surged 4807.69% in 2023 before it soared 58.53% in 2025.
- Over 5 years, Share-based Compensation stood at $218000.0 in 2022, then skyrocketed by 568.35% to $1.5 million in 2023, then surged by 115.1% to $3.1 million in 2024, then skyrocketed by 68.63% to $5.3 million in 2025, then increased by 23.9% to $6.5 million in 2026.
- Business Quant data shows Share-based Compensation for MLYS at $6.5 million in Q1 2026, $5.3 million in Q4 2025, and $5.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 257.40 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | 6.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.55 Mn |
| Mar 31, 2026 | 6.55 Mn |
| Dec 31, 2025 | 5.29 Mn |
| Dec 31, 2025 | 5.29 Mn |
| Sep 30, 2025 | 5.84 Mn |
| Sep 30, 2025 | 5.84 Mn |
| Jun 30, 2025 | 4.55 Mn |
| Jun 30, 2025 | 4.55 Mn |
| Mar 31, 2025 | 3.65 Mn |
| Mar 31, 2025 | 3.65 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 2.19 Mn |
| Mar 31, 2024 | 2.19 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 749,000.00 |
| Mar 31, 2023 | 749,000.00 |
| Dec 31, 2022 | 218,000.00 |
| Dec 31, 2022 | 218,000.00 |
| Sep 30, 2022 | 192,000.00 |
| Sep 30, 2022 | 192,000.00 |
| Jun 30, 2022 | 26,000.00 |
| Jun 30, 2022 | 26,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Mar 31, 2022 | 19,000.00 |